Method and apparatus for termination of ventricular tachycardia and ventricular fibrillation

• US 5,224,475 A
• Filed: 11/20/1991
• Issued: 07/06/1993
• Est. Priority Date: 11/20/1991
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Rossing, Martin A., Berg, Gary L., Peterson, David K., Neumann, Robert A.
• Primary Examiner(s): Howell, Kyle L.
• Assistant Examiner(s): SCHAETZLE, KENNEDY
• Application Number:
  US07/795,211
• Time in Patent Office: 594 Days
• Field of Search: 128/419 D, 128/419 PT, 128/734, 128/908
• US Class Current: 607/8
• CPC Class Codes: A61N 1/3918 characterised by shock pathway, e.g. by electrode configuration
• CPC Class Codes: A61N 1/3931 Protecting, e.g. back-up systems

Abstract

An implantable defibrillator provided with a plurality of defibrillation electrodes, which may be reconfigured to define a plurality of defibrillation pathways. The device is capable of measuring the impedance along a selected defibrillation pathway, during delivery of an impedance pulse, and monitoring the success or failure of the pulse to accomplish defibrillation or cardioversion. In response to a detected failure to accomplish cardioversion in conjunction with a measured change of impedance of greater than a predetermined amount, a new defibrillation pathway is selected, which may employ some or all of the electrodes employed to define the original impedance pathway. The device also includes apparatus for varying the relative amplitude of defibrillation pulses applied to individual electrodes used in sequential or simultaneous, multiple electrode pulse regimens, in order to equalize current distribution, in response to measured pathway impedances.

Claims

1. An implantable cardioverter or defibrillator, comprising:

means for detecting the presence of a tachyarrhythmia;

pulse generator means for delivering a cardioversion or defibrillation pulse regimen in response to detection of a tachyarrhythmia by said detection means;

electrode means for delivering said cardioversion or defibrillation pulse regimen to a heart, said electrode means comprising a plurality of electrodes, said electrodes defining a plurality of pulse pathways between ones of said electrodes;

means for selecting which of said defibrillation pathways are to be employed during the delivery of said defibrillation or cardioversion pulse regimen;

means for measuring the impedance of each of said selected pathways during delivery of said cardioversion or defibrillation regimen;

means for defining a reference impedance for each of said selected pathways;

means for comparing each said measured impedance associated with delivery of said cardioversion or defibrillation pulse regimen with a said reference impedance for each said selected pathway to determine whether said measured impedance differs by more than a predetermined amount from said reference impedance;

means for determining whether said cardioversion or defibrillation pulse regimen was effective to terminate said detected tachyarrhythmia; and

means responsive to said comparing means and to said determining means for rendering any said pathway for which said measured impedance differs by more than said previous predetermined amount from said reference impedance unavailable for future cardioversion or defibrillation regimens, provided that said cardioversion or defibrillation pulse regimen is determined to be ineffective in terminating said detected tachyarrhythmia.

2. An implantable cardioverter or defibrillator according to claim 1 wherein said means for selecting further comprising means for selecting a defibrillation or cardioversion pulse regimen for subsequent use which does not employ said unavailable pathway.

3. An implantable cardioverter or defibrillator according to claim 1 or claim 2 wherein said means for defining a reference impedance comprises memory means for storing said measured impedances and wherein each said reference impedance comprises an impedance measurement stored in said memory means.

4. An implantable cardioverter or defibrillator according to claim 1 or claim 2 further comprising means for incrementing the amplitude of a subsequent cardioversion or defibrillation pulse regimen in response to said determining means determining that a previous cardioversion or defibrillation pulse regimen was ineffective to terminate said detected tachyarrhythmia.

5. An implantable cardioverter or defibrillator according to claim 1 or claim 2 further comprising means for adjusting the amplitude of a subsequent cardioversion or defibrillation pulse regimen in response to the measurement of the impedances of said selected pathways during delivery of said cardioversion or defibrillation pulse regimen.

6. An implantable cardioverter or defibrillator, comprising:

means for detecting the presence of a tachyarrhythmia;

pulse generator means for delivering a cardioversion or defibrillation pulse regimen in response to detection of a tachyarrhythmia by said detection means;

electrode means for delivering said cardioversion or defibrillation pulse regimen to a heart, said electrode means comprising a plurality of electrodes, said electrodes defining a plurality of pulse pathways between ones of said electrodes;

means for defining a first cardioversion or defibrillation pulse regimen and for selecting a set of said electrodes and a set of said defibrillation pathways to be employed during the delivery of a said first cardioversion or defibrillation pulse regimen;

means for defining a reference impedance for each of said selected pathways;

means for measuring the impedance of each of said selected pathways during delivery of said first cardioversion or defibrillation pulse regimen;

means for comparing each said measured impedance associated with delivery of said first cardioversion or defibrillation pulse regimen with a reference impedance for each said selected pathway to determine whether said measured impedance differs by more than a predetermined amount from said reference impedance; and

wherein

said selecting means is responsive to aid comparing means to define a second cardioversion or defibrillation pulse regimen employing all of said set of electrodes selected to deliver said first cardioversion or defibrillation regimen and which does not employ any said selected pathway for which said measured impedance differs by more than said predetermined amount from said reference impedance.

7. An implantable cardioverter or defibrillator according to claim 6 wherein said selecting means further comprises;

means for determining whether said cardioversion or defibrillation pulse regimen was effective to terminate said detected tachyarrhythmia; and

means responsive to said comparing means and to said determining means for rendering any said selected pathway for which said measured impedance differs by more than said predetermined amount from said reference impedance unavailable for delivery of future cardioversion or defibrillation regimens when that said cardioversion or defibrillation pulse regimen is determined to be ineffective to terminate said detected tachyarrhythmia.

8. An implanted cardioverter or defibrillator according to claim 6 or claim 7 wherein said means for defining a reference impedance comprises memory means for storing said measured impedances and wherein each said reference impedance comprises an impedance measurement stored in said memory means.

9. An implantable cardioverter or defibrillator according to claim 7 further comprising means for incrementing the amplitude of a subsequent cardioversion or defibrillation pulse regimen in response to said determining means determining that a previous cardioversion or defibrillation pulse regimen was ineffective to terminate said detected tachyarrhythmia.

10. An implantable cardioverter or defibrillator according to claim 6 or claim 7 further comprising means for adjusting the amplitude of a subsequent cardioversion or defibrillation pulse regimen in response to the measurement of the impedances of said selected pathways during delivery of said cardioversion or defibrillation pulse regimen.